We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

119 hedge funds and large institutions have $341M invested in Spectrum Pharmaceuticals Inc in 2014 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 43 increasing their positions, 38 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 14

13% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 38

3% more funds holding

Funds holding: 115119 (+4)

10% less capital invested

Capital invested by funds: $377M → $341M (-$36.6M)

63% less call options, than puts

Call options by funds: $1.08M | Put options by funds: $2.91M

Holders
119
Holders Change
+4
Holders Change %
+3.48%
% of All Funds
3.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
43
Reduced
38
Closed
14
Calls
$1.08M
Puts
$2.91M
Net Calls
-$1.83M
Net Calls Change
-$87K
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
1
Millennium Management
New York
$36.9M +$8.19M +967,332 +26%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$36M -$12.3M -1,447,900 -24%
BFA
3
BlackRock Fund Advisors
California
$31.5M -$2.65M -313,153 -7%
Vanguard Group
4
Vanguard Group
Pennsylvania
$29.1M +$635K +75,085 +2%
State Street
5
State Street
Massachusetts
$26.4M +$5.57M +658,564 +24%
BIT
6
BlackRock Institutional Trust
California
$14.4M +$327K +38,619 +2%
Goldman Sachs
7
Goldman Sachs
New York
$10.9M +$493K +58,213 +4%
FCAM
8
F&C Asset Management
United Kingdom
$10.2M -$4.41M -521,013 -29%
DM
9
Deerfield Management
New York
$9.92M -$9.28M -1,096,030 -46%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$9.83M -$38.9K -4,600 -0.4%
Federated Hermes
11
Federated Hermes
Pennsylvania
$8.08M +$8.72M +1,030,645 New
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$8M -$1.29M -152,632 -13%
RCAMU
13
Rothschild & Co Asset Management US
Connecticut
$7.66M +$8.26M +976,560 New
KCM
14
Kennedy Capital Management
Missouri
$7.42M +$103K +12,212 +1%
Barclays
15
Barclays
United Kingdom
$7.16M +$101K +11,970 +1%
Wellington Management Group
16
Wellington Management Group
Massachusetts
$6.78M -$263K -31,058 -3%
Northern Trust
17
Northern Trust
Illinois
$6.68M -$544K -64,338 -7%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$4.35M -$103K -12,222 -2%
JAM
19
Jupiter Asset Management
United Kingdom
$4.35M +$4.69M +554,762 New
ACM
20
Ashford Capital Management
Delaware
$4.29M +$4.63M +547,404 New
PAI
21
Palo Alto Investors
California
$3.15M
Principal Financial Group
22
Principal Financial Group
Iowa
$2.74M +$161K +18,966 +6%
FLAM
23
First Light Asset Management
Minnesota
$2.74M +$2.96M +349,267 New
TCIM
24
TIAA CREF Investment Management
New York
$2.25M -$35.6K -4,210 -1%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$2.24M +$85.2K +10,063 +4%

SPPI Hedge Fund Activity: Q1 2014 in Review

119 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2014, worth a combined $341M — down 9.7% from $377M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new SPPI positions and 14 closed out — a net gain of 4 holders — while 43 added to existing stakes and 38 trimmed.

The largest buyer was Federated Hermes, opening a new position worth an estimated $8.72M. The largest seller was Fidelity Investments, cutting an estimated $12.3M.

  • 119 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2014, up from 115 in Q4 2013.
  • Funds reported $341M of Spectrum Pharmaceuticals Inc stock for Q1 2014, down 9.7% quarter-over-quarter.
  • 18 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2014 and 14 closed out, a net change of +4 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q1 2014 was Federated Hermes, an estimated $8.72M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q1 2014 was Fidelity Investments, an estimated $12.3M sold.

Based on aggregated 13F filings for Q1 2014.